1. Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy

   • Katarina Berinder
   • Thomas Nyström
   • Anna-Lena Hulting

   OriginalPaper 03 December 2010 Pages: 199 - 207

   

2. Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency

   • Helena Filipsson Nyström
   • Alexandru Saveanu
   • Thierry Brue

   OriginalPaper 05 December 2010 Pages: 208 - 216

   

3. Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population

   • Pedro Weslley Rosario

   OriginalPaper 18 December 2010 Pages: 217 - 221

   

4. Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists

   • Muriel Babey
   • Rahel Sahli
   • Rolf W. Seiler

   OriginalPaper Open access 18 December 2010 Pages: 222 - 230

   

5. Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism

   • Ana Laura Espinosa-de-los-Monteros
   • Baldomero González
   • Moisés Mercado

   OriginalPaper 16 December 2010 Pages: 231 - 235

6. Intrapituitary cytokines in Cushing’s disease: do they play a role?

   • Agostino Paoletta
   • Giorgio Arnaldi
   • Giacomo Tirabassi

   OriginalPaper 23 December 2010 Pages: 236 - 241

7. AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cells

   • Giovanni Tulipano
   • Michela Giovannini
   • Daniela Cocchi

   OriginalPaper 07 January 2011 Pages: 242 - 252

   

8. Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients

   • Sebastian J. C. M. M. Neggers
   • Wouter W. de Herder
   • A. J. van der Lely

   OriginalPaper Open access 08 January 2011 Pages: 253 - 258

   

9. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis

   • Vania dos Santos Nunes
   • Regina El Dib
   • Célia Regina Nogueira

   OriginalPaper 08 January 2011 Pages: 259 - 265

   

10. The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas

    • Lubin Qiu
    • Dongsheng He
    • Haijun Wang

    OriginalPaper 30 January 2011 Pages: 266 - 275

    

11. Excess mortality for patients with residual disease following resection of pituitary adenomas

    • Michael E. Sughrue
    • Edward F. Chang
    • Lewis S. Blevins

    ReviewPaper 08 April 2011 Pages: 276 - 283

    

12. Clinical, quality of life, and economic value of acromegaly disease control

    • A. Ben-Shlomo
    • M. C. Sheppard
    • S. Melmed

    ReviewPaper Open access 20 May 2011 Pages: 284 - 294

    

13. Successful treatment of Cushing’s disease caused by ectopic intracavernous microadenoma

    • Mitsuteru Koizumi
    • Takeshi Usui
    • Akira Shimatsu

    Case Report 03 December 2008 Pages: 295 - 298